Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	334.61	399.27	276.47	869.19	397.66	683.29
Short-Term Investments	2,156	1,938	1,721	1,264	1,501	1,825
Cash & Short-Term Investments	2,491	2,338	1,997	2,133	1,899	2,509
Cash Growth	11.10%	17.03%	-6.36%	12.32%	-24.30%	20.23%
Receivables	17.93	97.78	25.54	61.9	76.2	63.03
Inventory	28.45	28.43	22.03	24.81	21.97	18.18
Other Current Assets	176.5	178.15	157.72	125.17	133.42	130.62
Total Current Assets	2,714	2,642	2,203	2,345	2,131	2,721
Property, Plant & Equipment	246.93	242.94	255.84	196.04	181.08	153.65
Long-Term Investments	41.02	42.99	40.37	32.32	15.06	10
Other Intangible Assets	-	-	-	-	27.94	25.67
Long-Term Deferred Tax Assets	-	-	-	-	-	305.56
Other Long-Term Assets	79.3	62.29	34.97	38.28	34.97	17.63
Total Assets	3,081	2,990	2,534	2,612	2,390	3,233
Accounts Payable	9.05	26.03	17.92	11.9	17.2	16.07
Accrued Expenses	164.95	215.62	189.28	127.37	155.89	104.13
Current Portion of Long-Term Debt	54.5	45.07	0.32	0.9	316.11	-
Current Portion of Leases	-	8.09	7.22	2.63	-	2.03
Current Income Taxes Payable	0.04	2.15	6.25	0.04	1.32	32.51
Current Unearned Revenue	76.02	151.13	90.58	97.71	108.38	118.27
Total Current Liabilities	304.57	448.09	311.56	240.55	598.9	273.01
Long-Term Debt	1,772	1,743	1,183	1,228	623.53	785.5
Long-Term Leases	168.37	170.88	178.94	19.43	-	-
Long-Term Unearned Revenue	173.78	241.18	287.77	351.88	424.05	490.06
Total Liabilities	2,419	2,603	1,961	1,840	1,646	1,549
Common Stock	0.16	0.14	0.14	0.14	0.14	0.14
Additional Paid-In Capital	2,832	2,215	2,060	1,964	1,896	2,204
Retained Earnings	-2,145	-1,796	-1,430	-1,160	-1,131	-707.53
Comprehensive Income & Other	-24.17	-32.65	-57.48	-32.67	-21.07	-25.29
Total Common Equity	662.47	386.69	572.89	771.74	743.28	1,471
Minority Interest	-	-	-	-	-	213.45
Shareholders' Equity	662.47	386.69	572.89	771.74	743.28	1,685
Total Liabilities & Equity	3,081	2,990	2,534	2,612	2,390	3,233
Total Debt	1,995	1,967	1,369	1,251	939.64	787.53
Net Cash (Debt)	496.19	370.23	628.21	882.13	959.48	1,721
Net Cash Growth	85.72%	-41.07%	-28.78%	-8.06%	-44.26%	19.54%
Net Cash Per Share	3.40	2.59	4.43	6.26	6.87	11.24
Filing Date Shares Outstanding	157.9	145.75	142.95	141.69	140.86	139.22
Total Common Shares Outstanding	157.81	144.34	142.06	141.21	140.37	140.34
Working Capital	2,409	2,194	1,891	2,104	1,532	2,448
Book Value Per Share	4.20	2.68	4.03	5.47	5.30	10.48
Tangible Book Value	662.47	386.69	572.89	771.74	715.35	1,445
Tangible Book Value Per Share	4.20	2.68	4.03	5.47	5.10	10.30
Land	-	8.57	8.57	23.06	23.06	23.06
Buildings	-	41.23	41.16	144.05	137.88	119.83
Machinery	-	9.84	9.58	10.59	12.87	7.35
Leasehold Improvements	-	28.28	28.36	20.14	17.26	13.6

Source: S&P Capital IQ. Standard template. Financial Sources.